0001140361-21-019780.txt : 20210603 0001140361-21-019780.hdr.sgml : 20210603 20210603200106 ACCESSION NUMBER: 0001140361-21-019780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMON IRWIN D CENTRAL INDEX KEY: 0000922748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 21994366 MAIL ADDRESS: STREET 1: C/O THE HAIN CELESTIAL GROUP INC. STREET 2: 1111 MARCUS AVENUE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 4 1 form4.xml FORM 4 X0306 4 2021-06-01 0001731348 Tilray, Inc. TLRY 0000922748 SIMON IRWIN D C/O TILRAY, INC. 745 FIFTH AVENUE, SUITE 1602 NEW YORK NY 10151 true true President and CEO Class 2 Common Stock 2021-06-01 4 M 0 72683 A 285003 D Class 2 Common Stock 2021-06-01 4 F 0 36248 16.98 D 248755 D Class 2 Common Stock 2021-06-01 4 M 0 242277 A 491032 D Class 2 Common Stock 2021-06-01 4 F 0 120824 16.98 D 370208 D Restricted Stock Units 2021-06-01 4 M 0 72683 0 D Class 2 Common Stock 72683 72693 D Restricted Stock Units 2021-06-01 4 M 0 242277 0 D Class 2 Common Stock 242277 242313 D These shares were retained by Tilray, Inc. via settlement on a net withholding basis in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of restricted stock units granted to the Reporting Person on January 22, 2020. Restricted stock units convert into shares of Class 2 Common Stock on a one-for-one basis. On January 22, 2020, the reporting person was granted 218,038 restricted stock units, 33.33% of which vested on June 1, 2020; 33.33% of which vested on June 1, 2021; and the remaining 33.34% of which will vest on June 1, 2022. On January 22, 2020, the reporting person was granted 726,794 restricted stock units, 33.33% of which vested on June 1, 2020; 33.33% of which vested on June 1, 2021; and the remaining 33.34% of which will vest on June 1, 2022. /s/ Carl A. Merton, as Attorney-in-Fact for Irwin D. Simon 2021-06-03